Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
SEC23IP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
DICER1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
AAMDC - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FKBP8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TNFAIP8L3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
UBAC2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EIF4G3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
COG3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC00216 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors
TBL1X - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
APLP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C11orf54 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC5A3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CSRP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TAOK3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SDCCAG8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ORMDL2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
UGT8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on